Search Results - "Borody, T"

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease by Foell, D, Wittkowski, H, Ren, Z, Turton, J, Pang, G, Daebritz, J, Ehrchen, J, Heidemann, J, Borody, T, Roth, J, Clancy, R

“…Phagocyte-derived S100 proteins are endogenous activators of innate immune responses. S100A12 binds to the receptor for advanced glycation end-products, while…”
Get full text

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 by Santin, A.D., Scheim, D.E., McCullough, P.A., Yagisawa, M., Borody, T.J.

“…In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the…”
Get full text

Efficacy and safety of rifabutin‐containing ‘rescue therapy’ for resistant Helicobacter pylori infection by BORODY, T. J., PANG, G., WETTSTEIN, A. R., CLANCY, R., HERDMAN, K., SURACE, R., LLORENTE, R., NG, C.

“…Summary Background  Current ‘rescue’ therapies provide inadequate Helicobacter pylori eradication rates because of antibiotic resistance. Aim  To test the…”
Get full text

Efficacy and safety of single‐triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study by O'Morain, C., Borody, T., Farley, A., De Boer, W. A., Dallaire, C., Schuman, R., Piotrowski, J., Fallone, C. A., Tytgat, G., Mégraud, F., Spénard, J.

“…Summary Background : The high prevalence of Helicobacter pylori resistance to metronidazole demands treatments more effective than standard bismuth‐based…”
Get full text

MAP-associated Crohn's Disease: MAP, Koch's postulates, causality and Crohn's Disease by Chamberlin, W., Borody, T., Naser, S.

Get full text

Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars by Borody, T.J, Bilkey, S, Wettstein, A.R, Leis, S, Pang, G, Tye, S

“…Abstract Background A possible causative link between Crohn's disease and Mycobacterium avium ss paratuberculosis has been suggested. Aim To report unique…”
Get full text

“flora power”—fecal bacteria cure chronic C. difficile diarrhea by Borody, Thomas J

Get full text

Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure? by Borody, T.J., Leis, S., Warren, E.F, Surace, R.

“…Background. Mycobacterium avium subspecies paratuberculosis is probably the best candidate for a microbial cause of Crohn's disease although arguments to the…”
Get full text

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori by Borody, T J, Andrews, P, Fracchia, G, Brandl, S, Shortis, N P, Bae, H

“…Triple therapy has been recommended as the most effective treatment for Helicobacter pylori eradication. Despite achieving a comparatively high eradication…”
Get full text

Severe recurrent Crohn’s disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy by Borody, T J, Heifets, L B

“…[...]they have omitted perhaps the most important potential pathogen, Mycobacterium avium ss paratuberculosis (MAP), the leading candidate causal agent of…”
Get full text

Lactoferrin: milking ulcers? by Borody, T.J, Ashman, O

Get full text

MAP-associated Crohn's Disease by Chamberlin, W, Borody, T, Naser, S

Get full text

Cure of duodenal ulcer after eradication of Helicobacter pylori by George, L L, Borody, T J, Andrews, P, Devine, M, Moore-Jones, D, Walton, M, Brandl, S

“…Eighty-two patients, whose duodenal ulcers were recurrent or resistant to H2-receptor antagonist therapy, were entered in a treatment protocol of ranitidine…”
Get more information

Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication by Borody, T J, Cole, P, Noonan, S, Morgan, A, Lenne, J, Hyland, L, Brandl, S, Borody, E G, George, L L

“…The role of Campylobacter pylori gastritis in dyspepsia could be clarified more readily if reliable eradication therapy were available. Antibiotic monotherapy…”
Get more information

Laparoscopic excision of a Brunner's gland hamartoma of the duodenum by Baladas, H G, Borody, T J, Smith, G S, Dempsey, M B, Richardson, M A, Falk, G L

“…Brunner's gland hamartoma (adenoma) was first described in 1876. It is a rare hamartomatous lesion, with only 100 cases reported in the world literature…”
Get full text

Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens by de Boer, W A, Thys, J C, Borody, T J, Graham, D Y, O'Morain, C, Tytgat, G N

“…Many antibiotic regimens for treating Helicobacter pylori infection are currently used in clinical trials. The reported side-effect profiles of similar…”
Get more information

Helicobacter pylori-negative duodenal ulcer by Borody, T J, George, L L, Brandl, S, Andrews, P, Ostapowicz, N, Hyland, L, Devine, M

“…Most patients with chronic duodenal ulcer (DU) craters have gastritis associated with Helicobacter pylori (HP), now thought to be the major cause of DU. A…”
Get more information

Campylobacter pyloridis gastritis I: Detection of urease as a marker of bacterial colonization and gastritis by Hazell, S L, Borody, T J, Gal, A, Lee, A

“…A method to detect the presence of Campylobacter pyloridis in dyspeptic patients is described. The test procedure involves placing a gastric pinch biopsy into…”
Get more information

Evaluation of anti‐Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populations by Ren, Z., Borody, T., Pang, G., Dunkley, M., Clancy, R., Xia, H. H. X., Chu, K. M., Wong, J., Wong, B. C. Y.

“…Summary Background : The performance of commercial Helicobacter pylori diagnostic kits developed for particular geographic regions has often been found to be…”
Get full text

Helicobacter pylori reinfection rate, in patients with cured duodenal ulcer by Borody, T J, Andrews, P, Mancuso, N, McCauley, D, Jankiewicz, E, Ferch, N, Shortis, N P, Brandl, S

“…To determine the reinfection rate of the gastric mucosa in patients previously cured of duodenal ulcers, following the eradication of Helicobacter pylori. Only…”
Get more information